Kairos Pharma KAPA SEC Filings

NYSE KAPA
$1.73 +0.07 (+3.92%)
As of: Sep 10, 2026 · 2:21 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Kairos Pharma, LTD. (KAPA) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index